IP Library › Granted Patent US 12,565,507
Granted Patent B2
US 12,565,507 · App. 17/785,952 · Granted Mar 3, 2026

Diorganomagnesium compound

Inventors: Julien Thuilliez (Clermont-Ferrand, FR); Robert Ngo (Clermont-Ferrand, FR); François Jean-Baptiste-Dit-Dominique (Clermont-Ferrand, FR)
Assignee: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
C07F3/02C08F210/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,565,507
App. No.
17/785,952
Granted
Mar 3, 2026
Kind
B2
Abstract

A diorganomagnesium compound of formula R B —Mg—R A is provided. R B is different from R A , R B comprises a benzene nucleus substituted with a magnesium atom, one of the carbon atoms of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbour and which is meta to the magnesium. The other carbon atom of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl or an isopropyl. R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, which diorganomagnesium compound is other than n-butylmesitylmagnesium. When used as co-catalyst of a metallocene, it makes it possible to increase the functional group content in the synthesis of a functional polymer.

Claims (42)

1 . An asymmetric diorganomagnesium compound of formula (I)

R B —Mg—R A   (I),

R B being different from R A ,

R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl,

R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted,

wherein the diorganomagnesium compound is other than n-butylmesitylmagnesium.

2 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents an alkyl containing from 2 to 10 carbon atoms.

3 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents a linear alkyl.

4 . A process for preparing an asymmetric diorganomagnesium compound of formula R B —Mg—R A , which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X,

M representing a lithium, sodium or potassium atom,

X representing a leaving group,

R B being different from R A ,

R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl,

R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, said diorganomagnesium compound being other than n-butylmesitylmagnesium.

5 . The process according to claim 4 , in which X is a halogen atom.

6 . The process according to claim 4 , in which X is a bromine atom or a chlorine atom.

7 . The process according to claim 4 , in which M represents a lithium atom.

8 . The asymmetric diorganomagnesium compound according to claim 1 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl.

9 . The asymmetric diorganomagnesium compound according to claim 2 , in which R A represents an alkyl containing from 2 to 8 carbon atoms.

10 . The process according to claim 6 , in which X is a bromine atom.

11 . The process according to claim 4 , in which, if one of the two carbon atoms of the benzene ring of R B ortho to the magnesium atom is substituted with an isopropyl, the second carbon atom of the benzene ring of R B ortho to the magnesium atom is not substituted with an isopropyl.

12 . The process according to claim 4 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl or an ethyl.

13 . A process for preparing an asymmetric diorganomagnesium compound of formula (II)

in which R 1 and R 5 represent a methyl or an ethyl,

R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl,

R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted,

which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X,

the organomagnesium agent of formula R B —Mg—X being of the formula:

M representing a lithium, sodium or potassium atom, and

X representing a leaving group,

said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium.

14 . An asymmetric diorganomagnesium compound of formula (II)

in which

R 1 and R 5 represent a methyl or an ethyl,

R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl,

R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium.

15 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 , R 3 and R 5 are identical.

16 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 2 and R 4 represent a hydrogen atom.

17 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents an alkyl containing from 2 to 10 carbon atoms.

18 . The asymmetric diorganomagnesium compound according to claim 17 , in which R A represents an alkyl containing from 2 to 8 carbon atoms.

19 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents a linear alkyl.

20 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 and R 5 represent a methyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2022
From: THUILLIEZ, JULIEN; NGO, ROBERT; JEAN-BAPTISTE-DIT-DOMINIQUE, FRANCOIS
To: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
Reel/Frame 060491/0921 →
Priority Claims (1)
FR 1914627 · Dec 17, 2019 · national
Continuity (1)
Related Publication 20230047483A1 · Feb 16, 2023
References Cited (22)
US 4124751A · Fischer et al. · 1978 [cited by applicant]
US 4870039A · Job · 1989 [cited by examiner]
US 4870040A · Job · 1989 [cited by examiner]
US 6372681B1 · Yamada · 2002 [cited by examiner]
US 20140378630A1 · McCauley et al. · 2014 [cited by applicant]
US 20180362679A1 · Kim et al. · 2018 [cited by applicant]
US 20190263954A1 · Lafaquiere · 2019 [cited by examiner]
US 20230357462A1 · Thuilliez · 2023 [cited by examiner]
US 20240117080A1 · Ngo · 2024 [cited by examiner]
EP 1092731A1 · 2001 [cited by applicant]
EP 2797969A1 · 2014 [cited by applicant]
EP 3387067A1 · 2018 [cited by applicant]
WO 2004035639A1 · 2004 [cited by applicant]
WO WO2007054224A2 · 2007 [cited by examiner]
WO WO2007128601A2 · 2007 [cited by examiner]
WO WO2013101861A1 · 2013 [cited by examiner]
WO 2018224776A1 · 2018 [cited by applicant]
E. Ashby et al., 43 Journal of Organic Chemistry, 4094-4098 (1978) (Year: 1978). [cited by examiner]
Reetz et al., 31 Angew. Chem., Int. Ed. Engl., 342-344 (1992) (Year: 1992). [cited by examiner]
CAS Abstract and Indexed Compound, P. Knochel et al., WO 2007/128601 (2007) (Year: 2007). [cited by examiner]
Email Communication from CAS Customer Center Regarding RN 956897-71-5 (Apr. 2, 2025) (Year: 2025). [cited by examiner]
International Search Report and Written Opinion with English translation mailed Apr. 20, 2021 for International Application No. PCT/FR2020/052428, 11 pages. [cited by applicant]